{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:10:58Z","timestamp":1784182258421,"version":"3.55.0"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["2023YFC2508200"],"award-info":[{"award-number":["2023YFC2508200"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["7222058"],"award-info":[{"award-number":["7222058"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["7244342"],"award-info":[{"award-number":["7244342"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["DFL20241201"],"award-info":[{"award-number":["DFL20241201"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Alopecia areata (AA) is an autoimmune disease characterized by non-scarring hair loss. Janus kinase (JAK) inhibitors have emerged as effective therapeutic options for severe pediatric AA, though repigmentation of white hair during treatment remains rarely reported. Herein, we report an unusual case of complete hair regeneration with simultaneous white-to-black hair conversion in a child with severe AA following JAK inhibitor therapy. An 11-year-old girl presented with alopecia totalis (AT) persisting for two years. She initially received baricitinib for seven months, achieving SALT 65% with predominantly white and gray hair regrowth. After switching to ritlecitinib 50\u2005mg\/day, black hair emerged at 6 weeks, with complete hair regrowth and repigmentation at 6 months (SALT 0). The patient has now completed 12 months of ritlecitinib therapy with sustained response and stable pigmentation. Family Dermatology Life Quality Index (FDLQI) decreased from 18 to 4. No significant adverse effects were observed. This case suggests that prolonged JAK inhibition may facilitate both hair regrowth and pigment restoration in pediatric severe AA.<\/jats:p>","DOI":"10.3389\/fped.2026.1867141","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:39:57Z","timestamp":1784180397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor"],"prefix":"10.3389","volume":"14","author":[{"given":"Yanhong","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Dermatology, National Center for Children\u2019s Health, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Center for Children\u2019s Health, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Center for Children\u2019s Health, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Center for Children\u2019s Health, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Center for Children\u2019s Health, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2025.09.008","article-title":"Ritlecitinib for severe alopecia areata in children under 12 years: a retrospective review of 18 cases","volume":"94","author":"Wang","year":"2026","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00403-025-03848-1","article-title":"Jak inhibitor intraclass switch in alopecia areata patients: a retrospective review of cases at an academic center","volume":"317","author":"Silva","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/archdermatol.2009.51","article-title":"Marie antoinette syndrome","volume":"145","author":"Navarini","year":"2009","journal-title":"Arch Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1440-0960.2007.00390.x","article-title":"A case of widespread non-pigmented hair regrowth in diffuse alopecia areata","volume":"48","author":"Dinh","year":"2007","journal-title":"Australas J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1067\/mjd.2002.120604","article-title":"Persistent depigmented regrowth after alopecia areata","volume":"46","author":"Wade","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1111\/jocd.16288","article-title":"Two case studies of persistent white hair regrowth after alopecia areata turning pigmented following treatment","volume":"23","author":"Tian","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"955035","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104496","DOI":"10.1016\/j.ad.2025.104496","article-title":"Real-world safety and efficacy profile of JAK inhibitors in pediatric alopecia areata: a multicenter retrospective study","volume":"117","author":"Mansilla-Polo","year":"2026","journal-title":"Actas Dermosifiliogr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/jdv.20311","article-title":"Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: commonalities and differences","volume":"39","author":"Yamaguchi","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e76287","DOI":"10.7759\/cureus.76287","article-title":"Unexpected extensive hair whitening following baricitinib treatment for alopecia Universalis: a case report and mechanistic insights","volume":"16","author":"Lawati Limbu","year":"2024","journal-title":"Cureus"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1867141\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:00Z","timestamp":1784180400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1867141\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":11,"alternative-id":["10.3389\/fped.2026.1867141"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1867141","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1867141"}}